Effect of Kangfuxin liquid combined with mupirocin on exit-site granulation tissue hyperplasia in peritoneal dialysis patients
10.3760/cma.j.issn.1008-6706.2019.02.007
- VernacularTitle:康复新液联合莫匹罗星软膏治疗腹膜透析隧道口肉芽组织增生的疗效观察
- Author:
Liqiu HUANG
1
;
Jiaqi XU
;
Jiamin TANG
;
Huiming HUANG
;
Yunfang ZHANG
Author Information
1. 广州市花都区人民医院肾病学科 510800
- Keywords:
Peritoneal dialysis;
Granulation tissue;
Kangfu Xin Ye;
Mupirocin
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(2):154-156
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of Kangfuxin liquid combined with mupirocin on exit -site granulation tissue hyperplasia in peritoneal dialysis patients. Methods From January 2012 to December 2017, 35 peritoneal dialysis patients with exit-site granulation tissue hyperplasia in the People's Hospital of Huadu District were selected and randomly assigned into treatment group (15 cases) and control group(20 cases). The control group was given conventional treatment, the treatment group received a sterile dressing moistened with Kangfuxin liquid. Before and after treatment,the exit-site granulation tissue outcome and the incidence of complications were recorded and compared. Results The recovery time of the control group was (8. 58 ± 1. 36)d,which was longer than (3. 43 ± 0. 85)d of the treatment group (t=3. 57,P<0. 05). Exit-site exudation was found in 3 patients of the control group. No complications were observed in the treatment group. Conclusion Kangfuxin liquid combined with mupiro-cin can shorter the recovery time of exit-site granulation tissue hyperplasia in peritoneal dialysis patients,and reduce the side effect,which is worthy of clinical application.
